Wet AMD Treatment Susvimo Preserves Vision for Five Years in Phase 3 Clinical Trial
Foundation Fighting Blindness

Wet AMD Treatment Susvimo Preserves Vision for Five Years in Phase 3 Clinical Trial

2025-08-06
Susvimo is an FDA-approved treatment that continuously delivers drug through a tiny, implanted capsule
Comments (3)

More Episodes

All Episodes>>

Get this podcast on your phone, Free

Create Your Podcast In Minutes

  • Full-featured podcast site
  • Unlimited storage and bandwidth
  • Comprehensive podcast stats
  • Distribute to Apple Podcasts, Spotify, and more
  • Make money with your podcast
Get Started
It is Free